Clinical Trial Update: AI-Based Prediction of HCC Recurrence Patterns After Resection (APAR)

View source ↗

Summary

A clinical trial at Tongji Hospital is evaluating an AI-based model to predict recurrence patterns of hepatocellular carcinoma after liver resection (APAR); the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Tongji Hospital | Conditions: Hepatecellular Carcinoma, Hepatectomy | Status: RECRUITING